OsteoPrime Forte
Natural health product licensed in Canada
- Other names
- OsteoPrime
- Licence holder
- Nature's Way of Canada Ltd.
- NPN or DIN-HM
- 80066420
- Status
- Active licence
- Licence date
- 15 January 2016
- Revision date
- 22 October 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6.25 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Molybdène Source : Molybdate de sodium (VI) | 12.5 mcg | 12.5 µg |
| Folate Source : Folate | 200 mcg | Not calculated |
| Manganèse Source : Aspartate de manganèse (II) | 1.75 mg | 1,750 µg |
| Phosphore Source : Phosphate de calcium, tribasique | 24 mg | 24,000 µg |
| Magnésium Source : Oxyde de magnésium | 62.5 mg | 62,500 µg |
| Magnésium Source : Aspartate de magnésium | 62.5 mg | 62,500 µg |
| Cuivre Source : Gluconate de cuivre (II) | 500 mcg | 500 µg |
| Vitamine B12 Source : Vitamine B12 | 5 mcg | 5 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 6.25 mg | 6,250 µg |
| Vitamine C Source : Vitamine C | 25 mg | 25,000 µg |
| Vitamine D Source : Cholécalciférol | 3.75 mcg | 3.75 µg |
| Vitamine D Source : Cholécalciférol | 150 UI | 3.75 µg |
| Vitamine K1 Source : Vitamine K1 | 75 mcg | 75 µg |
| Thiamine Source : Chlorhydrate de thiamine | 5 mg | 5,000 µg |
| Riboflavine Source : Riboflavine | 5 mg | 5,000 µg |
| Niacinamide Source : Riboflavine | 12.5 mg | Not calculated |
| Calcium Source : Calcium | 150 mg | 150,000 µg |
| Calcium Source : Lactate de calcium | 150 mg | 150,000 µg |
| Calcium Source : Phosphate de calcium, tribasique | 150 mg | 150,000 µg |
| Calcium Source : Malate de calcium | 150 mg | 150,000 µg |
| Calcium Source : Citrate de calcium | 150 mg | 150,000 µg |
| Calcium Source : Fumarate de calcium | 150 mg | 150,000 µg |
| Calcium Source : Carbonate de calcium | 150 mg | 150,000 µg |
| Zinc Source : Picolinate de zinc | 5 mg | 5,000 µg |
| Sélénium Source : Sélénite de sodium | 25 mcg | 25 µg |
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium Source : Chlorhydrate de bétaine | 5 mg | Not calculated |
| Bore Source : Acide borique | 500 mcg | Not calculated |
| Strontium Source : Chlorure de strontium | 500 mcg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropyl méthylcellulose, Dioxyde de silicium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis / may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life). Helps maintain healthy calcium metabolism. Helps in the development and maintenance of bones and teeth. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in the absorption and use of calcium and phosphorus. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80066420
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vitamine D
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.